Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 12.
Article
Bell, GS;
Neligan, A;
Giavasi, C;
Keezer, MR;
Novy, J;
Peacock, JL;
Johnson, AL;
... Sander, JW; + view all
(2016)
Outcome of seizures in the general population after 25 years: a prospective follow-up, observational cohort study.
Journal of Neurology, Neurosurgery & Psychiatry
, 87
(8)
pp. 843-850.
10.1136/jnnp-2015-312314.
|
 |
|
Crawford, MJ;
Killaspy, H;
Kalaitzaki, E;
Barrett, B;
Byford, S;
Patterson, S;
Soteriou, T;
... Waller, D; + view all
(2010)
The MATISSE study: a randomised trial of group art therapy for people with schizophrenia.
BMC PSYCHIATRY
, 10
, Article 65. 10.1186/1471-244X-10-65.
|
 |
|
Howard, R;
McShane, R;
Lindesay, J;
Ritchie, C;
Baldwin, A;
Barber, R;
Burns, A;
... Phillips, P; + view all
(2012)
Donepezil and memantine for moderate-to-severe Alzheimer's disease.
The New England Journal of Medicine
, 366
(10)
893 - 903.
10.1056/NEJMoa1106668.
|
|
|
Howard, R;
McShane, R;
Lindesay, J;
Ritchie, C;
Baldwin, A;
Barber, R;
Burns, A;
... Phillips, PP; + view all
(2015)
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.
The Lancet Neurology
, 14
(12)
pp. 1171-1181.
10.1016/S1474-4422(15)00258-6.
|
|
Jones, R;
Sheehan, B;
Phillips, P;
Juszczak, E;
Adams, J;
Baldwin, A;
Ballard, C;
... DOMINO-AD team; + view all
(2009)
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
Trials
, 10
, Article 57. 10.1186/1745-6215-10-57.
|
|
|
Knapp, M;
King, D;
Romeo, R;
Adams, J;
Baldwin, A;
Ballard, C;
Banerjee, S;
... Howard, R; + view all
(2016)
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer’s disease (the DOMINO-AD trial).
International Journal of Geriatric Psychiatry
10.1002/gps.4583.
(In press).
|
|
|
O'Callaghan, FJ;
Edwards, SW;
Alber, FD;
Hancock, E;
Johnson, AL;
Kennedy, CR;
Likeman, M;
... Osborne, JP; + view all
(2016)
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
Lancet Neurology
, 16
(1)
pp. 33-42.
10.1016/S1474-4422(16)30294-0.
|
|
O'Callaghan, FJK;
Edwards, SW;
Dietrich Alber, F;
Cortina Borja, M;
Hancock, E;
Johnson, AL;
Kennedy, CR;
... Osborne, JP; + view all
(2018)
Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
The Lancet Child & Adolescent Health
, 2
(10)
pp. 715-725.
10.1016/S2352-4642(18)30244-X.
|
|
Osborne, JP;
Edwards, SW;
Alber, FD;
Hancock, E;
Johnson, AL;
Kennedy, CR;
Likeman, M;
... O'Callaghan, FJK; + view all
(2019)
The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS).
Epilepsia
, 60
(9)
pp. 1861-1869.
10.1111/epi.16305.
|
|
Spackman, E;
Sculpher, M;
Howard, J;
Malfroy, M;
Llewelyn, C;
Choo, L;
Hodge, R;
... Williamson, L; + view all
(2013)
Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial.
Eur J Haematol
, 92
(3)
pp. 249-255.
10.1111/ejh.12232.
|
|
|
Stanworth, SJ;
Morris, TP;
Gaarder, C;
Goslings, JC;
Maegele, M;
Cohen, MJ;
Koenig, TC;
... Brohi, K; + view all
(2010)
Reappraising the concept of massive transfusion in trauma.
Critical Care
, 14
(6)
, Article R239. 10.1186/cc9394.
|
|
|
Sydes, MR;
Johnson, AL;
Meredith, SK;
Rauchenberger, M;
South, A;
Parmar, MK;
(2015)
Sharing data from clinical trials: the rationale for a controlled access approach.
Trials
, 16
(1)
, Article 104. 10.1186/s13063-015-0604-6.
|
|
